A Case Report of LADA in the Primary Care Setting |
| |
| Institution: | 1. Department of Chemical and Biological Engineering, Koç University, Sar?yer, 34450, Istanbul, Turkey;2. Department of Pharmaceutical Biotechnology, School of Pharmacy, Altinbas University, Istanbul, 34144, Turkey;3. Pharmaceutical Application Laboratories, Ashland Specialty Ingredients, 34810, Istanbul, Turkey;4. Koç University Tüpra? Energy Center, Koç University, Sar?yer, 34450, Istanbul, Turkey;1. Department of Anesthesiology, George E. Wahlen Department of Veterans Affairs Medical Center, Salt Lake City, Salt Lake City, UT, USA;2. Department of Anesthesiology, University of Utah School of Medicine, Salt Lake City, UT, USA;3. Division of Epidemiology, Department of Internal Medicine, University of Utah School of Medicine, UT, USA;4. Division of Vascular Surgery, Department of Surgery, University of Utah School of Medicine, Salt Lake City, UT, USA |
| |
| Abstract: | Latent autoimmune diabetes in adults (LADA), a slowly progressing form of autoimmune diabetes, accounts for 2%–12% of all diabetes. Pancreatic beta cell function eventually deteriorates, rendering the patient insulin dependent and at risk for serious complications. All newly presenting adult persons with diabetes should be screened for LADA. In particular, consider LADA in those adults with a personal or family history of autoimmune conditions or those persons diagnosed with type 2 diabetes initially controlled on evidence-based therapies but then become difficult to manage and exhibit signs, such as unintended weight loss, that are more typical of persons with type 1 diabetes. |
| |
| Keywords: | diabetes diagnosis LADA LADA Expert Panel latent autoimmune diabetes in adults primary care type 1 5 diabetes |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
